These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 21585382)

  • 1. Influence of atorvastatin on fractional and subfractional composition of serum lipoproteins and MMP activity in mice with Triton WR 1339-induced lipaemia.
    Korolenko TA; Cherkanova MS; Tuzikov FV; Johnston TP; Tuzikova NA; Loginova VM; Kaledin VI
    J Pharm Pharmacol; 2011 Jun; 63(6):833-9. PubMed ID: 21585382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of atorvastatin and carboxymethylated glucan on the serum lipoprotein profile and MMP activity of mice with lipemia induced by poloxamer 407.
    Korolenko TA; Tuzikov FV; Cherkanova MS; Johnston TP; Tuzikova NA; Loginova VM; Filjushina EE; Kaledin VI
    Can J Physiol Pharmacol; 2012 Feb; 90(2):141-53. PubMed ID: 22320860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of repeated administration of poloxamer 407 on serum lipoproteins and protease activity in mouse liver and heart.
    Korolenko TA; Tuzikov FV; Johnston TP; Tuzikova NA; Kisarova YA; Zhanaeva SY; Alexeenko TV; Zhukova NA; Brak IV; Spiridonov VK; Filjushina EE; Cherkanova MS; Monoszon AA
    Can J Physiol Pharmacol; 2012 Nov; 90(11):1456-68. PubMed ID: 23181274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The role of changes in matrix metalloproteases and chitotriosidase in the mechanism of protective effect of atorvastatin in experimental murine lipemia].
    Korolenko TA; Cherkanova MS; Savchenko NG; Klishevich MS
    Eksp Klin Farmakol; 2009; 72(4):25-7. PubMed ID: 19803366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of bezafibrate and atorvastatin on lipoprotein subclass in patients with type III hyperlipoproteinemia: result from a crossover study.
    Kawashiri MA; Kobayashi J; Nohara A; Noguchi T; Tada H; Nakanishi C; Inazu A; Mabuchi H; Yamagishi M
    Clin Chim Acta; 2011 May; 412(11-12):1068-75. PubMed ID: 21354122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of short-term low-dose atorvastatin on low-density lipoprotein and high-density lipoprotein subfraction phenotype.
    Xu RX; Guo YL; Li XL; Li S; Li JJ
    Clin Exp Pharmacol Physiol; 2014 Jul; 41(7):475-81. PubMed ID: 24739131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effect of fenofibrate and atorvastatin on in vivo kinetics of apolipoproteins B-100 and B-48 in subjects with type 2 diabetes mellitus with marked hypertriglyceridemia.
    Hogue JC; Lamarche B; Deshaies Y; Tremblay AJ; Bergeron J; Gagné C; Couture P
    Metabolism; 2008 Feb; 57(2):246-54. PubMed ID: 18191056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative characteristics of lipemia models induced by injections of Triton WR-1339 and poloxamer 407 in mice.
    Loginova VM; Tuzikov FV; Tuzikova NA; Korolenko TA
    Bull Exp Biol Med; 2013 Jun; 155(2):284-7. PubMed ID: 24131010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atorvastatin or fenofibrate on post-prandial lipaemia in type 2 diabetic patients with hyperlipidaemia.
    Iovine C; Lilli S; Gentile A; Patti L; Di Marino L; Cipriano P; Riccardi G; Rivellese AA
    Eur J Clin Invest; 2006 Aug; 36(8):560-5. PubMed ID: 16893378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MDOC and atorvastatin have potential antiinflammatory effects in vascular endothelium of apoE-/- mouse model of atherosclerosis.
    Nachtigal P; Pospisilova N; Pospechova K; Jamborova G; Kopecky M; Jaynes R; Briestensky J; Santar I; Smahelova A; Solichova D; Zdansky P; Semecky V
    Life Sci; 2006 Mar; 78(17):1983-9. PubMed ID: 16305803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fractional composition of blood serum lipoproteins in mice and rats with Triton WR 1339-induced lipemia.
    Korolenko TA; Tuzikov FV; Vasil'eva ED; Cherkanova MS; Tuzikova NA
    Bull Exp Biol Med; 2010 Oct; 149(5):567-70. PubMed ID: 21165388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of atorvastatin on serum lipoproteins in acromegaly.
    Mishra M; Durrington P; Mackness M; Siddals KW; Kaushal K; Davies R; Gibson M; Ray DW
    Clin Endocrinol (Oxf); 2005 Jun; 62(6):650-5. PubMed ID: 15943824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypolipidaemic activity of orally administered diphenyl diselenide in Triton WR-1339-induced hyperlipidaemia in mice.
    da Rocha JT; Sperança A; Nogueira CW; Zeni G
    J Pharm Pharmacol; 2009 Dec; 61(12):1673-9. PubMed ID: 19958591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Determination of fractional and subfractional blood lipoprotein compositions with small angle X-ray scattering (a comparison with a biochemical method)].
    Tuzikov FV; Ragino IuI; Tuzikova NA; Ivanova MV; Galimov RV; Nikitin IuP
    Vopr Med Khim; 2002; 48(1):84-93. PubMed ID: 12068501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypolipidemic activity of Phellinus rimosus against triton WR-1339 and high cholesterol diet induced hyperlipidemic rats.
    Rony KA; Ajith TA; Nima N; Janardhanan KK
    Environ Toxicol Pharmacol; 2014 Mar; 37(2):482-92. PubMed ID: 24561532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Qualitative effect of fenofibrate and quantitative effect of atorvastatin on LDL profile in combined hyperlipidemia with dense LDL.
    Winkler K; Weltzien P; Friedrich I; Schmitz H; Nickell HH; Hauck P; Hoffmann MM; Baumstark MW; Wieland H; März W
    Exp Clin Endocrinol Diabetes; 2004 May; 112(5):241-7. PubMed ID: 15146369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipoprotein profile in patients who survive a stroke.
    Oravec S; Krivosikova Z; Krivosik M; Gruber K; Gruber M; Dukát A; Gavorník P
    Neuro Endocrinol Lett; 2011; 32(4):496-501. PubMed ID: 21876499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of ezetimibe/simvastatin on lipoprotein subfractions in patients with primary hypercholesterolemia: an exploratory analysis of archived samples using two commercially available techniques.
    Ose L; Reyes R; Johnson-Levonas AO; Sapre A; Tribble DL; Musliner T
    Clin Ther; 2007 Nov; 29(11):2419-32. PubMed ID: 18158082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of low-dose atorvastatin on lipid levels and endothelial vascular function in patients with significant coronary artery stenosis.
    Kuryata OV; Yegorova YV
    Kardiol Pol; 2006 Jan; 64(1):44-8; discussion 49-50. PubMed ID: 16444629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of atorvastatin on activities of matrix metalloproteinases and chitotriosidase in male and female mice with experimental hyperlipidemia.
    Korolenko TA; Cherkanova MS; Korolenko EC
    Bull Exp Biol Med; 2009 Sep; 148(3):369-73. PubMed ID: 20396691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.